Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Shao, Wei
NCT05908695: An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease	Recruiting	4	1312	RoW	GV-971, Placebo	Green Valley (Shanghai) Pharmaceuticals Co., Ltd.	Alzheimer's Disease	06/29	12/29
Chen, Liuqing
NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis	Recruiting	3	430	RoW	Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid	Eli Lilly and Company	Atopic Dermatitis	12/25	11/26
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis	Recruiting	3	552	RoW	ICP-332 Tablets, ICP-332 Placebo Tablets	Beijing InnoCare Pharma Tech Co., Ltd.	Atopic Dermatitis	11/26	12/26